Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma

Published:2008-06 Issue:9 Volume:9 Page:1609-1618
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Schöffski Patrick,Dumez Herlinde,Wolter Pascal,Stefan Cristiana,Wozniak Agnieszka,Jimeno Jose,Van Oosterom Allan T

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14656566.9.9.1609

Reference59 articles.

1. Cancer Statistics, 2004

2. Emerging drugs for the treatment of soft tissue sarcomas

3. Treatment of patients with advanced soft tissue sarcoma: disappointment or challenge?

4. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group

5. Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Depths of Marine Biotechnology: Discoveries, Diversity, and Future Horizons;Current Biotechnology;2024-03

2. Anticancer drugs that interact with the DNA minor groove;Medicinal Chemistry of Anticancer Drugs;2023

3. Biomaterials and Bioactive Natural Products from Marine Invertebrates: From Basic Research to Innovative Applications;Marine Drugs;2022-03-22

4. A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer;Advanced Science;2022-01-12

5. A Treasure of Bioactive Compounds from the Deep Sea;Biomedicines;2021-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3